Arca
Skip to content
Tools
Tools

Warning Letter to SyncThink, Inc.

Unspecified. See SyncThink's company page or this site's inspections.

On Jul 31, 2017, FDA's CDRH sent SyncThink, Inc. a warning letter citing 510(k) required.

  • Letter date: Jul 31, 2017
  • Issued by: CDRH
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

• “In the clinic or at the point of injury: advanced cognitive assessment.”

• “Introducing the future of mobile assessment technology: EYE-SYNC ® by SyncThink overcomes the limitations of traditional cognitive testing to provide an easy-to-use, rapid, objective tool for initial screening and recovery monitoring.”

• “Mobile, precise assessment of visual attention after a force to the head: EYE-SYNC ® uses high-performance, cutting-edge eye tracking technology to monitor eye movement in a handheld virtual reality environment. If your brain is out of sync after an on-field incident, SyncThink ® ’s technology will let you know in less than a minute.”

• “Screening and Recovery: EYE-SYNC ® helps you with screening in the field and assessing return to play or work in the clinic.”

• “EYE-SYNC ® is fast. Every second counts when assessing cognitive state on the field. EYE-SYNC ® ’s core technology takes less time than a medical timeout to administer.”

• “EYE-SYNC ® is reliable. SyncThink ® has tested its metrics on over 10,000 soldiers and athletes and shown a greater than 0.8 test-retest reliability-far exceeding other cognitive tests.”

• “In the clinic or at the point of injury: Cognitive assessment tools are tedious, inaccurate, or immobile. EYE-SYNC ® delivers world-class clinical tools from the playing field to the battlefield. Follow-up with the same toolset in a clinical setting to determine return-to-activity evaluation.”

• “Coaches and trainers need to make fast on-field decisions that might place an athlete in harm's way. The EYE-SYNC ® is a mobile, objective assessment that provides clarity after an injury.”

• “EYE-SYNC ® is a functional assessment that provides real-time information to commanders on the battlefield. Spot and care for injury before it becomes a danger to the mission.”

• “Stanford Sports Medicine uses EYE-SYNC ® technology currently to screen athletes for concussion and make decisions on return to play.”

The Firm's Other Letters

Same company or the same FDA site, newest first

Recent Letters Citing 510(k) required

See them all

Record

Recipient
—
FDA site ID (FEI)
3014133165

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.